INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 169 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $240,000 | -77.5% | 3,812 | -55.7% | 0.01% | -73.1% |
| Q4 2019 | $1,066,000 | +80.1% | 8,600 | -3.5% | 0.03% | +62.5% |
| Q3 2019 | $592,000 | -22.7% | 8,914 | -7.3% | 0.02% | -23.8% |
| Q2 2019 | $766,000 | +39.8% | 9,615 | +96.1% | 0.02% | +40.0% |
| Q1 2019 | $548,000 | +128.3% | 4,903 | +105.9% | 0.02% | +87.5% |
| Q4 2018 | $240,000 | -32.4% | 2,381 | -15.1% | 0.01% | -11.1% |
| Q3 2018 | $355,000 | -34.5% | 2,806 | -56.6% | 0.01% | -40.0% |
| Q2 2018 | $542,000 | +35.8% | 6,467 | -0.2% | 0.02% | +50.0% |
| Q1 2018 | $399,000 | +39.5% | 6,480 | +32.4% | 0.01% | +42.9% |
| Q4 2017 | $286,000 | +2.9% | 4,895 | +2.3% | 0.01% | 0.0% |
| Q3 2017 | $278,000 | +17.3% | 4,785 | +145.1% | 0.01% | 0.0% |
| Q2 2017 | $237,000 | -2.9% | 1,952 | -9.3% | 0.01% | 0.0% |
| Q1 2017 | $244,000 | +14.0% | 2,152 | +9.0% | 0.01% | +16.7% |
| Q4 2016 | $214,000 | -59.8% | 1,974 | -38.9% | 0.01% | -62.5% |
| Q3 2016 | $532,000 | -1.5% | 3,232 | -14.5% | 0.02% | 0.0% |
| Q2 2016 | $540,000 | +3.1% | 3,780 | -7.2% | 0.02% | 0.0% |
| Q1 2016 | $524,000 | -30.8% | 4,074 | -19.7% | 0.02% | -30.4% |
| Q4 2015 | $757,000 | -28.5% | 5,071 | -20.6% | 0.02% | -28.1% |
| Q3 2015 | $1,059,000 | -8.9% | 6,387 | +32.7% | 0.03% | 0.0% |
| Q2 2015 | $1,162,000 | +0.2% | 4,812 | +17.0% | 0.03% | 0.0% |
| Q1 2015 | $1,160,000 | +9.1% | 4,114 | -39.7% | 0.03% | +3.2% |
| Q4 2014 | $1,063,000 | +19.0% | 6,819 | +80.6% | 0.03% | +14.8% |
| Q3 2014 | $893,000 | +85.3% | 3,775 | +85.4% | 0.03% | +80.0% |
| Q2 2014 | $482,000 | -28.8% | 2,036 | -0.7% | 0.02% | -25.0% |
| Q1 2014 | $677,000 | – | 2,051 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |